Iovance Biotherapeutics
IOVA
#3883
Rank
NZ$5.83 B
Marketcap
NZ$12.61
Share price
-5.61%
Change (1 day)
216.18%
Change (1 year)

Earnings for Iovance Biotherapeutics (IOVA)

Earnings in 2026 (TTM): -NZ$0.52 Billion

According to Iovance Biotherapeutics 's latest financial reports the company's current earnings are NZ$0.32 Billion. In 2025 the company made an earning of -NZ$0.73 Billion a decrease over its 2024 earnings that were of -NZ$0.73 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Iovance Biotherapeutics from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.52 Billion-29.4%
2025 -NZ$0.73 Billion0.74%
2024 -NZ$0.73 Billion-14.17%
2023 -NZ$0.85 Billion15.46%
2022 -NZ$0.73 Billion16.39%
2021 -NZ$0.63 Billion30.83%
2020 -NZ$0.48 Billion26.62%
2019 -NZ$0.38 Billion61.29%
2018 -NZ$0.24 Billion38.09%
2017 -NZ$0.17 Billion73.16%
2016 -NZ$98.06 Million92.7%
2015 -NZ$50.89 Million131.17%
2014 -NZ$22.02 Million-51.71%
2013 -NZ$45.59 Million6291.81%
2012 -NZ$0.72 Million
2008 -NZ$0.11 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-NZ$3.96 Million-99.27% Bahamas
NRC Health
NRC
NZ$27.03 M-104.99%๐Ÿ‡บ๐Ÿ‡ธ USA